Fibrocell Science Inc. | Mutual Funds
Mutual Funds that own Fibrocell Science Inc.
Vanguard Extended Market Index Fund
80,874
0.87%
0
0%
07/31/2018
Vanguard Total Stock Market Index Fund
39,114
0.42%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
8,368
0.09%
0
0%
07/31/2018
Vanguard Balanced Index Fund
3,110
0.03%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
2,592
0.03%
0
0%
07/31/2018
1,813
0.02%
0
0.01%
09/05/2018
Fidelity Nasdaq Composite Index
1,683
0.02%
1
0%
07/31/2018
Vanguard Institutional Total Stock Market Index Fund
613
0.01%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
555
0.01%
0
0%
09/06/2018
BlackRock Master Extended Market Index Series
306
0%
0
0%
01/31/2018
| Address |
405 Eagleview Boulevard
Exton Pennsylvania 19341
United States
|
|
Employees
|
- |
| Website |
http://www.fibrocell.com |
| Updated |
07/08/2019 |
| Fibrocell Science, Inc. is an autologous cell and gene therapy company, which engages in translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. Its clinical and pre-clinical programs include treatments for restrictive burn scars, vocal cord scars, and acne scars. The company was founded on September 1, 2009 and is headquartered in Exton, PA. |
